ID: ALA3972051

Max Phase: Preclinical

Molecular Formula: C25H32N6O6S2

Molecular Weight: 576.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)NCCCCC(=O)Nc1ccc(C[C@H](NC(=O)[C@@H]2CSCN2S(=O)(=O)c2ccccc2)C(=O)O)cc1

Standard InChI:  InChI=1S/C25H32N6O6S2/c26-25(27)28-13-5-4-8-22(32)29-18-11-9-17(10-12-18)14-20(24(34)35)30-23(33)21-15-38-16-31(21)39(36,37)19-6-2-1-3-7-19/h1-3,6-7,9-12,20-21H,4-5,8,13-16H2,(H,29,32)(H,30,33)(H,34,35)(H4,26,27,28)/t20-,21-/m0/s1

Standard InChI Key:  UYNCOPGHWUTKNM-SFTDATJTSA-N

Associated Targets(Human)

Integrin alpha-V/beta-1 222 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 576.70Molecular Weight (Monoisotopic): 576.1825AlogP: 1.15#Rotatable Bonds: 13
Polar Surface Area: 194.78Molecular Species: ZWITTERIONHBA: 7HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.12CX Basic pKa: 12.01CX LogP: -0.59CX LogD: -0.59
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.12Np Likeness Score: -0.99

References

1. Reed NI, Tang YZ, McIntosh J, Wu Y, Molnar KS, Civitavecchia A, Sheppard D, DeGrado WF, Jo H..  (2016)  Exploring N-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors.,  (10): [PMID:27774126] [10.1021/acsmedchemlett.6b00196]

Source